As part of the ASPET Council meeting last November, I had the opportunity to join members of the ASPET staff and Council for a visit with House and Senate legislators on Capitol Hill. This was a great chance to communicate ASPET’s vision and mission and discuss ongoing Society activities with policy makers.
A showcase of three early-career scientists—what drives them and why pharmacology is important to them.
Honoring ASPET members who have passed.
A biotech curriculum provides the skills and experiences students need to be successful in long-term, well-paid careers. While many high school science classes focus on lab-based activities, many do not cover the full-product development life cycle in biotech, which can prevent students from understanding and experiencing what a career in the biotech industry could mean for their future.
Listen to ASPET President Namandjé N. Bumpus, PhD as she discusses ASPET’s recent work with early-career scientists, important updates on ASPET 2024 registration and late abstracts opportunities.
As the professional home for pharmacology, ASPET welcomes everyone involved in the field, including early-career professionals. We recognize the unique needs of students, postdocs and other early career professionals and provide them with opportunities to develop both their skills and their career options.
Dolores C. Shockley: A Trailblazer in Pharmacology
A Conversation with Dianicha Santana, PhD, ASPET’s Young Scientists Committee Chair
Updates from some of our outstanding ASPET members.
ASPET’s public policy efforts play a pivotal role in shaping the science advocacy conversation. From advocating on Capitol Hill—including the ASPET Council and early-career members—to advocacy letter campaigns, the Society remains committed to keeping pharmacologists involved in the public conversation.
